Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1758

  • Quoted phrase not found.
1.

C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers.

Rizzu P, Blauwendraat C, Heetveld S, Lynes EM, Castillo-Lizardo M, Dhingra A, Pyz E, Hobert M, Synofzik M, Simón-Sánchez J, Francescatto M, Heutink P.

Acta Neuropathol Commun. 2016 Apr 14;4(1):37. doi: 10.1186/s40478-016-0306-7.

2.

Discovering EEG resting state alterations of semantic dementia.

Grieder M, Koenig T, Kinoshita T, Utsunomiya K, Wahlund LO, Dierks T, Nishida K.

Clin Neurophysiol. 2016 May;127(5):2175-81. doi: 10.1016/j.clinph.2016.01.025. Epub 2016 Feb 15.

PMID:
27072087
3.

Omega-3 fatty acids for the treatment of dementia.

Burckhardt M, Herke M, Wustmann T, Watzke S, Langer G, Fink A.

Cochrane Database Syst Rev. 2016 Apr 11;4:CD009002. doi: 10.1002/14651858.CD009002.pub3. Review.

PMID:
27063583
4.

MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases.

Harper L, Fumagalli GG, Barkhof F, Scheltens P, O'Brien JT, Bouwman F, Burton EJ, Rohrer JD, Fox NC, Ridgway GR, Schott JM.

Brain. 2016 Apr;139(Pt 4):1211-25. doi: 10.1093/brain/aww005. Epub 2016 Mar 1.

5.

Neural substrates of vulnerability to postsurgical delirium as revealed by presurgical diffusion MRI.

Cavallari M, Dai W, Guttmann CR, Meier DS, Ngo LH, Hshieh TT, Callahan AE, Fong TG, Schmitt E, Dickerson BC, Press DZ, Marcantonio ER, Jones RN, Inouye SK, Alsop DC; SAGES Study Group.

Brain. 2016 Apr;139(Pt 4):1282-94. doi: 10.1093/brain/aww010. Epub 2016 Feb 26.

PMID:
26920674
6.

The Role of APOE in the Occurrence of Frontotemporal Dementia in Amyotrophic Lateral Sclerosis.

Chiò A, Brunetti M, Barberis M, Iazzolino B, Montuschi A, Ilardi A, Cammarosano S, Canosa A, Moglia C, Calvo A.

JAMA Neurol. 2016 Apr;73(4):425-30. doi: 10.1001/jamaneurol.2015.4773.

PMID:
26903389
7.

Parkinsonism, movement disorders and genetics in frontotemporal dementia.

Baizabal-Carvallo JF, Jankovic J.

Nat Rev Neurol. 2016 Mar;12(3):175-85. doi: 10.1038/nrneurol.2016.14. Epub 2016 Feb 19. Review.

PMID:
26891767
8.

Increased CSF neurogranin concentration is specific to Alzheimer disease.

Wellington H, Paterson RW, Portelius E, Törnqvist U, Magdalinou N, Fox NC, Blennow K, Schott JM, Zetterberg H.

Neurology. 2016 Mar 1;86(9):829-35. doi: 10.1212/WNL.0000000000002423. Epub 2016 Jan 29.

9.

Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism.

Ahmed RM, Irish M, Piguet O, Halliday GM, Ittner LM, Farooqi S, Hodges JR, Kiernan MC.

Lancet Neurol. 2016 Mar;15(3):332-42. doi: 10.1016/S1474-4422(15)00380-4. Epub 2016 Jan 26. Review. Erratum in: Lancet Neurol. 2016 Apr;15(4):352.

PMID:
26822748
10.

On the right side? A longitudinal study of left- versus right-lateralized semantic dementia.

Kumfor F, Landin-Romero R, Devenney E, Hutchings R, Grasso R, Hodges JR, Piguet O.

Brain. 2016 Mar;139(Pt 3):986-98. doi: 10.1093/brain/awv387. Epub 2016 Jan 25.

PMID:
26811253
11.

Assessment of Eating Behavior Disturbance and Associated Neural Networks in Frontotemporal Dementia.

Ahmed RM, Irish M, Henning E, Dermody N, Bartley L, Kiernan MC, Piguet O, Farooqi S, Hodges JR.

JAMA Neurol. 2016 Mar;73(3):282-90. doi: 10.1001/jamaneurol.2015.4478.

PMID:
26810632
12.

Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort.

Murphy J, Factor-Litvak P, Goetz R, Lomen-Hoerth C, Nagy PL, Hupf J, Singleton J, Woolley S, Andrews H, Heitzman D, Bedlack RS, Katz JS, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Koczon-Jaremko BA, Mitsumoto H; ALS COSMOS.

Neurology. 2016 Mar 1;86(9):813-20. doi: 10.1212/WNL.0000000000002305. Epub 2016 Jan 22.

PMID:
26802094
13.

Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage.

Ranasinghe KG, Rankin KP, Lobach IV, Kramer JH, Sturm VE, Bettcher BM, Possin K, Christine You S, Lamarre AK, Shany-Ur T, Stephens ML, Perry DC, Lee SE, Miller ZA, Gorno-Tempini ML, Rosen HJ, Boxer A, Seeley WW, Rabinovici GD, Vossel KA, Miller BL.

Neurology. 2016 Feb 16;86(7):600-10. doi: 10.1212/WNL.0000000000002373. Epub 2016 Jan 22.

PMID:
26802093
14.

Profiling Speech and Pausing in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).

Yunusova Y, Graham NL, Shellikeri S, Phuong K, Kulkarni M, Rochon E, Tang-Wai DF, Chow TW, Black SE, Zinman LH, Green JR.

PLoS One. 2016 Jan 20;11(1):e0147573. doi: 10.1371/journal.pone.0147573. eCollection 2016.

15.

Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations.

Creavin ST, Wisniewski S, Noel-Storr AH, Trevelyan CM, Hampton T, Rayment D, Thom VM, Nash KJ, Elhamoui H, Milligan R, Patel AS, Tsivos DV, Wing T, Phillips E, Kellman SM, Shackleton HL, Singleton GF, Neale BE, Watton ME, Cullum S.

Cochrane Database Syst Rev. 2016 Jan 13;(1):CD011145. doi: 10.1002/14651858.CD011145.pub2. Review.

PMID:
26760674
16.

Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.

Hannan SB, Dräger NM, Rasse TM, Voigt A, Jahn TR.

J Neurochem. 2016 Apr;137(1):12-25. doi: 10.1111/jnc.13532. Epub 2016 Feb 11. Review.

PMID:
26756400
17.

Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases.

van Waalwijk van Doorn LJ, Koel-Simmelink MJ, Haußmann U, Klafki H, Struyfs H, Linning P, Knölker HJ, Twaalfhoven H, Kuiperij HB, Engelborghs S, Scheltens P, Verbeek MM, Vanmechelen E, Wiltfang J, Teunissen CE.

J Neurochem. 2016 Apr;137(1):112-21. doi: 10.1111/jnc.13527. Epub 2016 Jan 24.

PMID:
26748905
18.

NREM sleep transient events in fronto-temporal dementia: beyond sleep stage architecture.

Maestri M, Carnicelli L, Economou NT, Bonakis A, Paparrigopoulos T, Papageorgiou ST, Giorgi FS, Di Coscio E, Tognoni G, Ferri R, Bonuccelli U, Bonanni E.

Arch Ital Biol. 2015 Jun-Sep;153(2-3):214-24. doi: 10.12871/0003982920152346.

PMID:
26742675
19.

The value of FDG-PET/CT by using 3-dimensional stereotactic surface projection software analysis in the differential diagnosis of dementia.

Arslan E, Ekmekçioğlu Ö, Görtan FA, Engin Akcan ZF, Erkan ME, Emül HM, Halaç M, Çermik TF, Sönmezoğlu K.

Turk J Med Sci. 2015;45(5):1149-58.

PMID:
26738361
20.

Impairments in the Face-Processing Network in Developmental Prosopagnosia and Semantic Dementia.

Mendez MF, Ringman JM, Shapira JS.

Cogn Behav Neurol. 2015 Dec;28(4):188-97. doi: 10.1097/WNN.0000000000000077.

PMID:
26705265
Items per page

Supplemental Content

Loading ...
Write to the Help Desk